Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Oikonomidi, I. Tsilioni, K. Gourgoulianis, T. Kiropoulos (Larissa, Greece). The diagnostic value of matrix metalloproteinases -8 and -9 in pleural effusions. Eur Respir J 2008; 32: Suppl. 52, 3526

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic values of matrix metalloproteinase-2 and -9 in exudative pleural effusions Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009 Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions Source: Eur Respir J 2005; 25: 104-109 Year: 2005 Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Matrix metalloprotease-1 and tissue inhibitor of metalloprotease-1 levels in pleural effusions of different origins Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004 Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo Source: Eur Respir J 2002; 20: 170-176 Year: 2002 Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002 Expression of matrix metalloproteinases (MMPs) in primary spontaneous pneumothorax: MMP-9 as a potential biomarker for surgical intervention Source: International Congress 2017 – Thoracic surgery Year: 2017 Matrix metalloproteinases in pulmonary fibrosis Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis Year: 2013 The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Matrix remodeling in IPF: the important role of MMPs-1, -2, -9 and TIMP-1, TIM-2 Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004 Osteopontin and matrix metalloproteinase-7 in bronchoalveolar lavage as markers of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007 Metalloproteinases, tissue inhibitors of metalloproteinases and TGF-β as predictors of pleura thickening in pleural tuberculosis Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation Source: Eur Respir J 2009; 33: 134-141 Year: 2009 Matrix metalloproteinases in tuberculosis Source: Eur Respir J 2011; 38: 456-464 Year: 2011 Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space Source: Eur Respir J 2008; 32: 644-650 Year: 2008 Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils Source: Eur Respir J 2009; 34: 1167-1170 Year: 2009 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019